Human health matters. That is why SCHOTT Pharma designs containment solutions grounded in science to ensure that medications are safe and easy to use for people around the world. Every minute, more than 30,000 people receive an injection packed in a SCHOTT Pharma product. The portfolio comprises drug containment solutions and delivery systems for injectable drugs ranging from prefillable glass and polymer syringes to cartridges, vials, and ampoules. Every day, a team of around 4,800 people from over 65 nations works at SCHOTT Pharma to contribute to global health.

The company is represented in all main pharmaceutical hubs with 17 manufacturing sites in Europe, North and South America, and Asia.

With over 1,000 patents and technologies developed in-house and a state-of-the-art R&D center in Switzerland, the company is focused on developing innovations for the future. Currently, SCHOTT Pharma has over 1,800 customers, including the top 30 leading pharma manufacturers for injectable drugs, and generated revenue of EUR 986 million in the financial year 2025. SCHOTT Pharma AG & Co. KGaA is headquartered in Mainz, Germany, and listed on the Frankfurt Stock Exchange as part of the SDAX. It is majority owned by SCHOTT AG, which is owned by the Carl Zeiss Foundation.

In light of this spirit, SCHOTT Pharma is committed to sustainable development for society and the environment. Further information at www.schott-pharma.com

SCHOTT Pharma offers a comprehensive portfolio of solutions for injectable drugs, covering both drug containment solutions and drug delivery systems. Its portfolio consists of:

• High-quality pharmaceutical glass vials designed for the secure storage of injectable drugs.
• Robust pharmaceutical glass and polymer cartridges for the accurate dosing of self-administered drugs.
• Ready-to-use prefillable glass and polymer syringes for safe, precise, and reliable drug storage and injection.
• Glass ampoules for safeguarding sensitive medication and retaining its integrity during storage and administration.

With its comprehensive service offering, SCHOTT Pharma supports the life cycle of drug development, from the research phase to the commercial. The services range from developing solutions for drug containment and delivery to performing packaging-related analytical tests and optimizing fill-and-finish processes, as well as providing sustainability and regulatory support.